COMP <GO>
KVUE vs PG // RSI-14 & 200D SMA MOMENTUM
Kenvue Inc. (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: KVUE 5
— PG 9
▲ RSI-14 & 200D SMA MOMENTUM LEADER: PG
LAST: $19.31 (-1.28%) • MKT CAP: $37.57B
rsi-technicals
60.0
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
rsi-technicals
62.7
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KVUE VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KVUE | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 58.10% | 51.20% | +6.90 | KVUE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.50% | 25.40% | -13.90 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.4x | 16.2x | -0.80 | KVUE | /valuation <GO> |
| Free Cash Flow Yield | 4.58% | 3.77% | +0.81 | KVUE | /fcf-yield <GO> |
| Operating Margin | 16.00% | 24.30% | -8.30 | PG | /operating-margins <GO> |
| Net Profit Margin | 9.70% | 19.00% | -9.30 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | -2.10% | 0.30% | -2.40 | PG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.21% | 2.65% | +1.56 | KVUE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.21 | 5.59 | -3.38 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 6.50% | +0.60 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 60.0 | 62.7 | -2.70 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 0.87 | +0.18 | KVUE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.8x | 21.7x | +2.10 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $37.57B | $372.21B | -$334.64B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KVUE REV | PG REV | KVUE GROSS % | PG GROSS % | KVUE FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $15.12B | $84.28B | 58.1% | 51.2% | $1.72B | $14.04B |
| FY 2024 | $15.46B | $84.04B | 58.0% | 51.4% | $1.33B | $16.52B |
| FY 2023 | $15.44B | $82.01B | 44.0% | 44.0% | $2.47B | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KVUE // BETA 1.05
PG // BETA 0.87